Dock Street Asset Management Inc Abb Vie Inc. Transaction History

Dock Street Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 31, 2019	SELL	$65.7 - $83.98 $5.45 Million - $6.96 Million	-82,890 Closed	0 $0
Q1 2019 Apr 29, 2019	SELL	$77.14 - $90.79 $442,706 - $521,043	-5,739 Reduced 6.48%	82,890 $6.68 Million
Q4 2018 Jan 17, 2019	BUY	$77.85 - $96.01 $179,522 - $221,399	2,306 Added 2.67%	88,629 $8.17 Million
Q3 2018 Oct 23, 2018	BUY	$88.91 - $98.84 $136,565 - $151,818	1,536 Added 1.81%	86,323 $8.16 Million
Q2 2018 Jul 24, 2018	BUY	$89.78 - $106.23 $52,162 - $61,719	581 Added 0.69%	84,787 $7.86 Million
Q1 2018 Apr 24, 2018	BUY	$92.01 - $123.21 $310,625 - $415,956	3,376 Added 4.18%	84,206 $7.97 Million
Q4 2017 Jan 29, 2018	BUY	$89.56 - $98.21 $694,179 - $761,225	7,751 Added 10.61%	80,830 $7.82 Million
Q3 2017 Oct 17, 2017	BUY	$69.85 - $89.22 $5.1 Million - $6.52 Million	73,079	73,079 $6.49 Million

3,694

1.27B

13M

9.79M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Dock Street Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Dock Street Asset Management Inc with notifications on news.